Donald Trump’s new 26% tariff on Indian imports has raised concerns about India's economic growth and export viability. While the pharmaceutical sector is temporarily exempt, brokerages warn of potential future tariffs and a significant impact on other export areas, including autos and IT services.
from Stocks-Markets-Economic Times https://ift.tt/GxzimJ4
Trump’s 26% tariff on India worse than expected, brokerages warn of GDP hit
Related Posts:
Embedded as a risk, new Covid cycle could challenge Fed, recovery- Indiamart Q1 results: Net profit rises 19% to Rs 88 crore
- JSW Steel reports Rs 5,900 crore of PAT in Q1 of FY 22
- UltraTech reports a 114% jump in PAT at Rs 1,703 in Q1
- NSE-BSE bulk deals: Maven India Fund sells stake in ANI Integrated Services
0 Comments:
Post a Comment